Tranexamic Acid During Colonic Endoscopic Resection Procedures
Status:
Not yet recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
Colonoscopy with polypectomy reduces the incidence and mortality associated with colon
cancer. However, polypectomy is associated with adverse events such as bleeding. Tranexamic
acid (TXA) is a synthetic derivative of lysine that exerts antifibrinolytic effects and may
prevent bleeding. The investigators aim to evaluate the effect of local TXA on preventing
intraprocedural and postprocedural bleeding in patients undergoing endoscopic mucosal
resection (EMR) of large colon polyps.